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LETTERS TO THE EDITOR
In Reference to, “As-Needed Intravenous Antihypertensive
Therapy and Blood Pressure Control”
Taha Ayach, MD1, Aibek E. Mirrakhimov, MD1
Department of Medicine, Division of Hospital Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.
We read with great interest the study by Lipari
et al. published recently in the Journal of Hospital
Medicine.1 The authors addressed a commonly encoun-
tered issue about frequent use of intravenous (IV) anti-
hypertensives in asymptomatic hospitalized patients.
There is little published about treatment of acutely
elevated blood pressure in asymptomatic inpatients,
although the practice seems to be common and based
on poorly justified beliefs.2 We believe that many
healthcare providers “treat the numbers” in such situa-
tions by dangerous misuse of potent medications lead-
ing to potential safety concern, which is associated
with unnecessary risks and excess costs and possibly
increased length of stay, as demonstrated in previous
reports3 but not specifically addressed in this study.
So what can be done to address this problem? We argue
against routine ordering of “as needed” IV antihyperten-
sives, but rather encourage a confirmation of the accuracy
of measurements, assess patients and pay attention to con-
comitant conditions (eg, anxiety or pain), consider short-
acting oral antihypertensive medications, and focus on
patient safety rather than a false sense of healthcare team
self-comfort. We believe that hospitals’ leadership should
stress the importance of proper use of medications to both
clinicians and nursing staff.
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We appreciate the comments of Drs. Ayach and Mirra-
khimov. Our study found that the routine ordering of
“as needed” intravenous (IV) antihypertensives was
commonly done for patients who had blood pressure
(BP) elevations that did not post any imminent danger to
the patients.1 Thus, the preemptive ordering of IV BP
medications that would be administered without any
clinical assessment is a practice that cannot be defended.
We are in complete agreement that the accuracy of the
BP measurement should be undertaken along with con-
sideration of factors that might explain the BP elevation
such as hypoxia, hypercarbia, pain, and IV saline infu-
sions. However, we would not shift our prescribing hab-
its toward short-acting antihypertensives drugs (eg,
nifedipine) that were never approved for hypertension
treatment despite their use for this condition.2 Rather,
we put forth the approach of primarily focusing on the
aforementioned patient factors that may explain BP ele-
vations and, in situations where such conditions do not
exist, gradually up-titrate/optimize the prescribed oral
antihypertensive drug regimen while also emphasizing
prudent dietary changes (eg, low-sodium diet).3
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